808048- Germany – Pharmaceutical products – Open framework agreement on drug discounts pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V), with the possibility of joining at any time, so-called approval model 2025-04

World Biggest Tenders Source

This tender with title 808048- Germany – Pharmaceutical products – Open framework agreement on drug discounts pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V), with the possibility of joining at any time, so-called approval model 2025-04 has been published on Bidding Source portal dated 09 Dec 2025 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

Germany

Tender Title :

808048- Germany – Pharmaceutical products – Open framework agreement on drug discounts pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V), with the possibility of joining at any time, so-called approval model 2025-04

Tender Type :

Invitation for Bids

Reference No. :

808048

Country :

Germany

Publish Date :

9 Dec 2025

Closing Date :

5 Apr 2027

Notice Language :

English

Tender Categories (CPVs) :

Pharmaceutical products

Full Tender Details :

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

803675- Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2025-39 - Epoetin beta Germany 804419- Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2025-38 - PEG-Epoetin beta Germany 808691- Germany – Pharmaceutical products – Conclusion not excluding drug discount agreement pursuant to Section 130a Paragraph 8 SGB V by way of an open-house model for the active ingredient Latanoprost/Timolol (official ATC code: S01ED61), excluding N1, N2 and N3 Germany 808033- Germany – Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) from January 1, 2026 Germany 803445- Germany – Pharmaceutical products – Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V, by way of an open-house model for the active ingredient tamsulosin/dutasteride (WHO ATC code: G04CA52) Germany 803026- Germany – Pharmaceutical products – Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V, by way of an open-house model for the active ingredient posaconazole (WHO ATC code: J02AC04) Germany 804227-Awarded - Germany – Pharmaceutical products – 1/DLII6/PM028 Arzneimittel Hypertonie Germany 805900-Awarded - Germany – Pharmaceutical products – Opdivo 2026 -- <b>Contract Value: 1 000,00 EUR</b> Germany 809008- Germany – Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for various active ingredient(s)/combinations with the option to conclude such agreements at any time within the framework of the so-called Open House procedure. Germany 800535- Germany – Pharmaceutical products – Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V, by way of an open-house model for the active ingredient lisdexamfetamine (WHO ATC code: N06BA12) Germany

808048- Germany – Pharmaceutical products – Open framework agreement on drug discounts pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V), with the possibility of joining at any time, so-called approval model 2025-04

General Information

Germany

Similar Tenders

Pharmaceutical products Tenders

Germany Tenders

Europe Tenders

Tenders

info@biddingsource.com